Immunofluorescence Assay Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET OVERVIEW
Immunofluorescence is a light microscopy technique with a fluorescence microscope that is mainly used on microbiological samples. This technique employs the sensitivity of antibodies to their antigen to guide fluorescent dyes to particular biomolecule targets inside a cell, allowing visualisation of the target molecule's distribution within the sample. An epitope is the particular area of an antigen that an antibody recognises.
MARKET SCOPE
The "Global Immunofluorescence Assay Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Immunofluorescence Assay market with detailed market segmentation by type, product, disease, end use, and geography. The report provides key statistics on the market status of the leading Immunofluorescence Assay market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the global Immunofluorescence Assay market is segmented into Micro Immunofluorescence, Indirect Immunofluorescence, Direct Immunofluorescence.
- On the basis of product, the market is segmented into Antibodies, Kits & Reagents, Labeling Dyes, Instruments.
- On the basis of disease, the market is segmented into Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Others.
- On the basis of end use, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institute, Hospitals & Diagnostic Centers, Contract Research Organizations.
MARKET DYNAMICS
Drivers
- Increasing prevalence of chronic diseases
- Increasing R&D spending and growing healthcare spending.
- Emerging markets such as Brazil, China, and India are expected to offer potential growth opportunities
Restraints
- However the high rate of diagnostic kits and shortage of skilled labor.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Immunofluorescence Assay market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Immunofluorescence Assay market in these regions.
IMPACT OF COVID-19 ON IMMUNOFLUORESCENCE ASSAY MARKET
The excruciating need to screen and monitor a large number of patients for potential Sars-Cov-2 contamination is the primary source of concern for governments in all Covid-19-affected countries. As a result, the majority of them are suffering from extreme shortages of medical kits for checking for infection. Diagnostic virology entities are under immense pressure to provide reliable study packages, and laboratories around the globe are seeing a rise in demand for in-vitro or point-of-care testing capabilities.
Mrinal Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any. 
Have a question?
Speak to Analyst
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Immunofluorescence Assay market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Immunofluorescence Assay market in these regions.
IMPACT OF COVID-19 ON IMMUNOFLUORESCENCE ASSAY MARKET
The excruciating need to screen and monitor a large number of patients for potential Sars-Cov-2 contamination is the primary source of concern for governments in all Covid-19-affected countries. As a result, the majority of them are suffering from extreme shortages of medical kits for checking for infection. Diagnostic virology entities are under immense pressure to provide reliable study packages, and laboratories around the globe are seeing a rise in demand for in-vitro or point-of-care testing capabilities.
MARKET PLAYERS
The report covers key developments in the Immunofluorescence Assay market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Immunofluorescence Assay market are anticipated to lucrative growth opportunities in the future with the rising demand for Immunofluorescence Assay in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Immunofluorescence Assay market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Thermo Fisher Scientific Inc.
- Abcam plc.
- Bio-Rad Laboratories, Inc.
- PerkinElmer Inc.
- Merck KGaA
- BD
- Agilent Technologies, Inc.
- Enzo Life Sciences, Inc.
- Sino Biological Inc.
- Danaher
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Immunofluorescence Assay Market - By Type
1.3.2 Immunofluorescence Assay Market - By Products
1.3.3 Immunofluorescence Assay Market - By Disease
1.3.4 Immunofluorescence Assay Market - By End-User
1.3.5 Immunofluorescence Assay Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. IMMUNOFLUORESCENCE ASSAY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. IMMUNOFLUORESCENCE ASSAY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. IMMUNOFLUORESCENCE ASSAY MARKET - GLOBAL MARKET ANALYSIS
6.1. IMMUNOFLUORESCENCE ASSAY - GLOBAL MARKET OVERVIEW
6.2. IMMUNOFLUORESCENCE ASSAY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. IMMUNOFLUORESCENCE ASSAY MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MICRO IMMUNOFLUORESCENCE
7.3.1. Overview
7.3.2. Micro Immunofluorescence Market Forecast and Analysis
7.4. INDIRECT IMMUNOFLUORESCENCE
7.4.1. Overview
7.4.2. Indirect Immunofluorescence Market Forecast and Analysis
7.5. DIRECT IMMUNOFLUORESCENCE
7.5.1. Overview
7.5.2. Direct Immunofluorescence Market Forecast and Analysis
8. IMMUNOFLUORESCENCE ASSAY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCTS
8.1. OVERVIEW
8.2. PRODUCTS MARKET FORECASTS AND ANALYSIS
8.3. ANTIBODIES
8.3.1. Overview
8.3.2. Antibodies Market Forecast and Analysis
8.4. KITS AND REAGENTS
8.4.1. Overview
8.4.2. Kits and Reagents Market Forecast and Analysis
8.5. LABELING DYES
8.5.1. Overview
8.5.2. Labeling Dyes Market Forecast and Analysis
8.6. INSTRUMENTS
8.6.1. Overview
8.6.2. Instruments Market Forecast and Analysis
9. IMMUNOFLUORESCENCE ASSAY MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE
9.1. OVERVIEW
9.2. DISEASE MARKET FORECASTS AND ANALYSIS
9.3. CANCER
9.3.1. Overview
9.3.2. Cancer Market Forecast and Analysis
9.4. INFECTIOUS DISEASES
9.4.1. Overview
9.4.2. Infectious Diseases Market Forecast and Analysis
9.5. CARDIOVASCULAR DISEASES
9.5.1. Overview
9.5.2. Cardiovascular Diseases Market Forecast and Analysis
9.6. AUTOIMMUNE DISEASES
9.6.1. Overview
9.6.2. Autoimmune Diseases Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. IMMUNOFLUORESCENCE ASSAY MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
10.1. OVERVIEW
10.2. END-USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
10.4. ACADEMIC AND RESEARCH INSTITUTE
10.4.1. Overview
10.4.2. Academic and Research Institute Market Forecast and Analysis
10.5. HOSPITALS AND DIAGNOSTIC CENTERS
10.5.1. Overview
10.5.2. Hospitals and Diagnostic Centers Market Forecast and Analysis
10.6. CONTRACT RESEARCH ORGANIZATIONS
10.6.1. Overview
10.6.2. Contract Research Organizations Market Forecast and Analysis
11. IMMUNOFLUORESCENCE ASSAY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Immunofluorescence Assay Market Overview
11.1.2 North America Immunofluorescence Assay Market Forecasts and Analysis
11.1.3 North America Immunofluorescence Assay Market Forecasts and Analysis - By Type
11.1.4 North America Immunofluorescence Assay Market Forecasts and Analysis - By Products
11.1.5 North America Immunofluorescence Assay Market Forecasts and Analysis - By Disease
11.1.6 North America Immunofluorescence Assay Market Forecasts and Analysis - By End-User
11.1.7 North America Immunofluorescence Assay Market Forecasts and Analysis - By Countries
11.1.7.1 United States Immunofluorescence Assay Market
11.1.7.1.1 United States Immunofluorescence Assay Market by Type
11.1.7.1.2 United States Immunofluorescence Assay Market by Products
11.1.7.1.3 United States Immunofluorescence Assay Market by Disease
11.1.7.1.4 United States Immunofluorescence Assay Market by End-User
11.1.7.2 Canada Immunofluorescence Assay Market
11.1.7.2.1 Canada Immunofluorescence Assay Market by Type
11.1.7.2.2 Canada Immunofluorescence Assay Market by Products
11.1.7.2.3 Canada Immunofluorescence Assay Market by Disease
11.1.7.2.4 Canada Immunofluorescence Assay Market by End-User
11.1.7.3 Mexico Immunofluorescence Assay Market
11.1.7.3.1 Mexico Immunofluorescence Assay Market by Type
11.1.7.3.2 Mexico Immunofluorescence Assay Market by Products
11.1.7.3.3 Mexico Immunofluorescence Assay Market by Disease
11.1.7.3.4 Mexico Immunofluorescence Assay Market by End-User
11.2. EUROPE
11.2.1 Europe Immunofluorescence Assay Market Overview
11.2.2 Europe Immunofluorescence Assay Market Forecasts and Analysis
11.2.3 Europe Immunofluorescence Assay Market Forecasts and Analysis - By Type
11.2.4 Europe Immunofluorescence Assay Market Forecasts and Analysis - By Products
11.2.5 Europe Immunofluorescence Assay Market Forecasts and Analysis - By Disease
11.2.6 Europe Immunofluorescence Assay Market Forecasts and Analysis - By End-User
11.2.7 Europe Immunofluorescence Assay Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Immunofluorescence Assay Market
11.2.7.1.1 Germany Immunofluorescence Assay Market by Type
11.2.7.1.2 Germany Immunofluorescence Assay Market by Products
11.2.7.1.3 Germany Immunofluorescence Assay Market by Disease
11.2.7.1.4 Germany Immunofluorescence Assay Market by End-User
11.2.7.2 France Immunofluorescence Assay Market
11.2.7.2.1 France Immunofluorescence Assay Market by Type
11.2.7.2.2 France Immunofluorescence Assay Market by Products
11.2.7.2.3 France Immunofluorescence Assay Market by Disease
11.2.7.2.4 France Immunofluorescence Assay Market by End-User
11.2.7.3 Italy Immunofluorescence Assay Market
11.2.7.3.1 Italy Immunofluorescence Assay Market by Type
11.2.7.3.2 Italy Immunofluorescence Assay Market by Products
11.2.7.3.3 Italy Immunofluorescence Assay Market by Disease
11.2.7.3.4 Italy Immunofluorescence Assay Market by End-User
11.2.7.4 Spain Immunofluorescence Assay Market
11.2.7.4.1 Spain Immunofluorescence Assay Market by Type
11.2.7.4.2 Spain Immunofluorescence Assay Market by Products
11.2.7.4.3 Spain Immunofluorescence Assay Market by Disease
11.2.7.4.4 Spain Immunofluorescence Assay Market by End-User
11.2.7.5 United Kingdom Immunofluorescence Assay Market
11.2.7.5.1 United Kingdom Immunofluorescence Assay Market by Type
11.2.7.5.2 United Kingdom Immunofluorescence Assay Market by Products
11.2.7.5.3 United Kingdom Immunofluorescence Assay Market by Disease
11.2.7.5.4 United Kingdom Immunofluorescence Assay Market by End-User
11.2.7.6 Rest of Europe Immunofluorescence Assay Market
11.2.7.6.1 Rest of Europe Immunofluorescence Assay Market by Type
11.2.7.6.2 Rest of Europe Immunofluorescence Assay Market by Products
11.2.7.6.3 Rest of Europe Immunofluorescence Assay Market by Disease
11.2.7.6.4 Rest of Europe Immunofluorescence Assay Market by End-User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Immunofluorescence Assay Market Overview
11.3.2 Asia-Pacific Immunofluorescence Assay Market Forecasts and Analysis
11.3.3 Asia-Pacific Immunofluorescence Assay Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Immunofluorescence Assay Market Forecasts and Analysis - By Products
11.3.5 Asia-Pacific Immunofluorescence Assay Market Forecasts and Analysis - By Disease
11.3.6 Asia-Pacific Immunofluorescence Assay Market Forecasts and Analysis - By End-User
11.3.7 Asia-Pacific Immunofluorescence Assay Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Immunofluorescence Assay Market
11.3.7.1.1 Australia Immunofluorescence Assay Market by Type
11.3.7.1.2 Australia Immunofluorescence Assay Market by Products
11.3.7.1.3 Australia Immunofluorescence Assay Market by Disease
11.3.7.1.4 Australia Immunofluorescence Assay Market by End-User
11.3.7.2 China Immunofluorescence Assay Market
11.3.7.2.1 China Immunofluorescence Assay Market by Type
11.3.7.2.2 China Immunofluorescence Assay Market by Products
11.3.7.2.3 China Immunofluorescence Assay Market by Disease
11.3.7.2.4 China Immunofluorescence Assay Market by End-User
11.3.7.3 India Immunofluorescence Assay Market
11.3.7.3.1 India Immunofluorescence Assay Market by Type
11.3.7.3.2 India Immunofluorescence Assay Market by Products
11.3.7.3.3 India Immunofluorescence Assay Market by Disease
11.3.7.3.4 India Immunofluorescence Assay Market by End-User
11.3.7.4 Japan Immunofluorescence Assay Market
11.3.7.4.1 Japan Immunofluorescence Assay Market by Type
11.3.7.4.2 Japan Immunofluorescence Assay Market by Products
11.3.7.4.3 Japan Immunofluorescence Assay Market by Disease
11.3.7.4.4 Japan Immunofluorescence Assay Market by End-User
11.3.7.5 South Korea Immunofluorescence Assay Market
11.3.7.5.1 South Korea Immunofluorescence Assay Market by Type
11.3.7.5.2 South Korea Immunofluorescence Assay Market by Products
11.3.7.5.3 South Korea Immunofluorescence Assay Market by Disease
11.3.7.5.4 South Korea Immunofluorescence Assay Market by End-User
11.3.7.6 Rest of Asia-Pacific Immunofluorescence Assay Market
11.3.7.6.1 Rest of Asia-Pacific Immunofluorescence Assay Market by Type
11.3.7.6.2 Rest of Asia-Pacific Immunofluorescence Assay Market by Products
11.3.7.6.3 Rest of Asia-Pacific Immunofluorescence Assay Market by Disease
11.3.7.6.4 Rest of Asia-Pacific Immunofluorescence Assay Market by End-User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Immunofluorescence Assay Market Overview
11.4.2 Middle East and Africa Immunofluorescence Assay Market Forecasts and Analysis
11.4.3 Middle East and Africa Immunofluorescence Assay Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Immunofluorescence Assay Market Forecasts and Analysis - By Products
11.4.5 Middle East and Africa Immunofluorescence Assay Market Forecasts and Analysis - By Disease
11.4.6 Middle East and Africa Immunofluorescence Assay Market Forecasts and Analysis - By End-User
11.4.7 Middle East and Africa Immunofluorescence Assay Market Forecasts and Analysis - By Countries
11.4.7.1 Saudi Arabia Immunofluorescence Assay Market
11.4.7.1.1 Saudi Arabia Immunofluorescence Assay Market by Type
11.4.7.1.2 Saudi Arabia Immunofluorescence Assay Market by Products
11.4.7.1.3 Saudi Arabia Immunofluorescence Assay Market by Disease
11.4.7.1.4 Saudi Arabia Immunofluorescence Assay Market by End-User
11.4.7.2 U.A.E Immunofluorescence Assay Market
11.4.7.2.1 U.A.E Immunofluorescence Assay Market by Type
11.4.7.2.2 U.A.E Immunofluorescence Assay Market by Products
11.4.7.2.3 U.A.E Immunofluorescence Assay Market by Disease
11.4.7.2.4 U.A.E Immunofluorescence Assay Market by End-User
11.4.7.3 Iran Immunofluorescence Assay Market
11.4.7.3.1 Iran Immunofluorescence Assay Market by Type
11.4.7.3.2 Iran Immunofluorescence Assay Market by Products
11.4.7.3.3 Iran Immunofluorescence Assay Market by Disease
11.4.7.3.4 Iran Immunofluorescence Assay Market by End-User
11.4.7.4 Turkey Immunofluorescence Assay Market
11.4.7.4.1 Turkey Immunofluorescence Assay Market by Type
11.4.7.4.2 Turkey Immunofluorescence Assay Market by Products
11.4.7.4.3 Turkey Immunofluorescence Assay Market by Disease
11.4.7.4.4 Turkey Immunofluorescence Assay Market by End-User
11.4.7.5 Rest of Middle East and Africa Immunofluorescence Assay Market
11.4.7.5.1 Rest of Middle East and Africa Immunofluorescence Assay Market by Type
11.4.7.5.2 Rest of Middle East and Africa Immunofluorescence Assay Market by Products
11.4.7.5.3 Rest of Middle East and Africa Immunofluorescence Assay Market by Disease
11.4.7.5.4 Rest of Middle East and Africa Immunofluorescence Assay Market by End-User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Immunofluorescence Assay Market Overview
11.5.2 South and Central America Immunofluorescence Assay Market Forecasts and Analysis
11.5.3 South and Central America Immunofluorescence Assay Market Forecasts and Analysis - By Type
11.5.4 South and Central America Immunofluorescence Assay Market Forecasts and Analysis - By Products
11.5.5 South and Central America Immunofluorescence Assay Market Forecasts and Analysis - By Disease
11.5.6 South and Central America Immunofluorescence Assay Market Forecasts and Analysis - By End-User
11.5.7 South and Central America Immunofluorescence Assay Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Immunofluorescence Assay Market
11.5.7.1.1 Brazil Immunofluorescence Assay Market by Type
11.5.7.1.2 Brazil Immunofluorescence Assay Market by Products
11.5.7.1.3 Brazil Immunofluorescence Assay Market by Disease
11.5.7.1.4 Brazil Immunofluorescence Assay Market by End-User
11.5.7.2 Argentina Immunofluorescence Assay Market
11.5.7.2.1 Argentina Immunofluorescence Assay Market by Type
11.5.7.2.2 Argentina Immunofluorescence Assay Market by Products
11.5.7.2.3 Argentina Immunofluorescence Assay Market by Disease
11.5.7.2.4 Argentina Immunofluorescence Assay Market by End-User
11.5.7.3 Rest of South and Central America Immunofluorescence Assay Market
11.5.7.3.1 Rest of South and Central America Immunofluorescence Assay Market by Type
11.5.7.3.2 Rest of South and Central America Immunofluorescence Assay Market by Products
11.5.7.3.3 Rest of South and Central America Immunofluorescence Assay Market by Disease
11.5.7.3.4 Rest of South and Central America Immunofluorescence Assay Market by End-User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL IMMUNOFLUORESCENCE ASSAY MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. IMMUNOFLUORESCENCE ASSAY MARKET, KEY COMPANY PROFILES
14.1. THERMO FISHER SCIENTIFIC INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ABCAM PLC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BIO-RAD LABORATORIES, INC.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. PERKINELMER INC.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. MERCK KGAA
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. BD
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. AGILENT TECHNOLOGIES, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ENZO LIFE SCIENCES, INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. SINO BIOLOGICAL INC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. DANAHER
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
1. Thermo Fisher Scientific Inc.
2. Abcam plc.
3. Bio-Rad Laboratories, Inc.
4. PerkinElmer Inc.
5. Merck KGaA
6. BD
7. Agilent Technologies, Inc.
8. Enzo Life Sciences, Inc.
9. Sino Biological Inc.
10. Danaher
11. Cell Signaling Technology, Inc.
12. Bio SB
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For